Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov 28;17(44):4899-904.
doi: 10.3748/wjg.v17.i44.4899.

Clinical presentation and management of Fasciola hepatica infection: single-center experience

Affiliations

Clinical presentation and management of Fasciola hepatica infection: single-center experience

Muhsin Kaya et al. World J Gastroenterol. .

Abstract

Aim: To identify the characteristic clinical, laboratory and radiological findings and response to treatment in patients with fascioliasis.

Methods: Patients who were diagnosed with Fasciola hepatica infection were included in this prospective study. Initial clinical, laboratory and radiological findings were recorded. All patients were followed until a complete response was achieved or for 6 mo after treatment discontinuation.

Results: Fasciola hepatica infection was diagnosed in 30 patients (24 females; mean age: 42.6 years) between January 2008 and February 2011. Twenty-two (73%) patients had hepatic phase fascioliasis, 5 patients had biliary phase, and 3 patients had biliary phase associated with acute pancreatitis. Of the 8 patients with biliary phase fascioliasis, 2 patients displayed features that overlapped with both hepatic and biliary phase. Abdominal pain and right upper abdominal tenderness were the most prominent signs and symptoms in all patients. Eosinophilia was the most prominent laboratory abnormality in both patients with hepatic and biliary phase (100% and 50%, respectively). Multiple nodular lesions like micro-abscesses on abdominal computerized tomography were the main radiological findings in patients with hepatic phase. Small linear filling defects in the distal choledochus were the main endoscopic retrograde cholangiopancreatography (ERCP) findings in patients with biliary phase. Patients with hepatic phase were treated with triclabendazole alone, and patients with biliary phase were treated with triclabendazole and had live Fasciola hepatica extracted from the bile ducts during ERCP.

Conclusion: Fasciola hepatica infection should be considered in the differential diagnosis of patients with hepatic or biliary disease and/or acute pancreatitis associated with eosinophilia.

Keywords: Cholangitis; Fasciola hepatica; Liver abscesses; Pancreatitis; Triclabendazole.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A 19-year-old female patient presented with right upper abdominal pain and fever lasting 3 wk. Abdominal computerized tomographic examination showed enlargement of the liver and extensive micro-abscesses (arrows).
Figure 2
Figure 2
A 19-year-old female patient presented with right upper abdominal pain and fever lasting 3 wk. Abdominal computerized tomographic examination showed enlargement of the liver and extensive micro-abscesses (arrows).
Figure 3
Figure 3
A 70-year-old female patient presented with right upper abdominal pain lasting 16 wk. Abdominal computerized tomographic examination showed low density masses with hazy margins located to medial segment of the left lobe (arrow).
Figure 4
Figure 4
In the patient whose pre-treatment computerized tomographic image is shown in Figure 1, abdominal computerized tomographic examination showed residual lesions (arrow) and minimally enlarged spleen 6 mo after treatment with triclabendazole.
Figure 5
Figure 5
Live and mobil Fasciola hepatica removed from the choledochus by balloon catheter during endoscopic retrograde cholangiopancreatography. A: A 35-year-old female patient presented with acute pancreatitis associated with elevated liver enzymes. Endoscopic retrograde cholangiopancreatography image showed a radiolucent, roughly crescent-shaped shadow in the common bile duct (arrows); B: A 49-year-old female patient presented with acute cholangitis associated with eosinophilia. Arrow: Head of Fasciola hepatica; Arrowhead: Body of Fasciola hepatica.

References

    1. Lim JH, Mairiang E, Ahn GH. Biliary parasitic diseases including clonorchiasis, opisthorchiasis and fascioliasis. Abdom Imaging. 2007;33:157–165. - PubMed
    1. Parkinson M, O’Neill SM, Dalton JP. Endemic human fasciolosis in the Bolivian Altiplano. Epidemiol Infect. 2007;135:669–674. - PMC - PubMed
    1. Mas-Coma MS, Esteban JG, Bargues MD. Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ. 1999;77:340–346. - PMC - PubMed
    1. Koç Z, Ulusan S, Tokmak N. Hepatobiliary fascioliasis: imaging characteristics with a new finding. Diagn Interv Radiol. 2009;15:247–251. - PubMed
    1. Kabaalioğlu A, Cubuk M, Senol U, Cevikol C, Karaali K, Apaydin A, Sindel T, Lüleci E. Fascioliasis: US, CT, and MRI findings with new observations. Abdom Imaging. 2000;25:400–404. - PubMed

MeSH terms